{"id":"W4415105330","doi":"10.1093/bjd/ljaf398","title":"Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial","year":2025,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health; Queen's University; Hotel Dieu Hospital","funders":"Sanofi Genzyme; European Academy of Dermatology and Venereology; Idorsia Pharmaceuticals; Swedish Orphan Biovitrum; LEO Pharma; Servier; Genesis Pharma; UCB Pharma; Argenx; Galderma; XBiotech; InflaRx; Symphogen; Pfizer; Biogen; Incyte; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Novartis Pharma; European Commission; Springworks Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Bundesministerium für Bildung und Forschung; Cilag; Insmed; L'Oreal USA; Sanofi; AstraZeneca; Novocure; Celldex Therapeutics; Amgen; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Hidradenitis suppurativa; Randomized controlled trial; Post-hoc analysis; Post hoc; Clinical trial; Randomization","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002453778,0.001124234,0.002753352,0.0002861755,0.0003419402,0.0009948711,0.0005598926,0.001338453,0.004116715],"category_scores_gemma":[0.002140451,0.0004017496,0.002343015,0.0002987506,0.0008728232,0.0007136569,0.0003276524,0.001568366,0.0004438237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000446376,"about_ca_system_score_gemma":0.0006644306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004454413,"about_ca_topic_score_gemma":0.000899989,"domain_scores_codex":[0.9989977,0.0006158861,0.00008044735,0.000133388,0.00007412813,0.00009841626],"domain_scores_gemma":[0.9988187,0.0004684863,0.0002654304,0.00009213823,0.00008540072,0.0002699126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9821399,0.002600601,0.0005350036,0.001101529,0.001260392,0.00002225841,0.00002915146,0.00009851124,0.001785789,0.00005046956,0.0002991541,0.0100772],"study_design_scores_gemma":[0.9521537,0.04422296,0.002058619,0.00006700509,0.0006441872,0.00002288994,0.00001523404,0.0001580651,0.0002605575,0.00005739212,0.0003311625,0.000008080525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9798395,0.01324197,0.0005379571,0.000592223,0.0006522822,0.002523479,0.0007536362,0.00006838437,0.001790563],"genre_scores_gemma":[0.990185,0.003937004,0.0009629237,0.0006944052,0.0004986716,0.001928696,0.0006449607,0.00001489914,0.001133322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004116715,"threshold_uncertainty_score":0.01377177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03081501622689424,"score_gpt":0.3624890151933463,"score_spread":0.3316739989664521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}